Chernett Jorey
SEC insider (Form 3/4/5 filer). CIK 0002042077. 10% Owner at EXAGEN INC. (XGN) and 3 other issuers. 49 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in BLOOMFIELD HILLS, MI.
Companies Chernett Jorey has filed insider reports for
- EXAGEN INC. (XGN): 10% Owner
- Neuronetics, Inc. (STIM): 10% Owner
- Starling Oncology, Inc. (STLN): 10% Owner
- Airsculpt Technologies, Inc. (AIRS): 10% Owner
Chernett Jorey
CIK: 0002042077
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (49 total)
- Oct 19, 2026XGN
EXAGEN INC.
PurchaseDirect14K shares at avg. $7.46$104K - Aug 14, 2026STIM
Neuronetics, Inc.
PurchaseDirect14K shares at avg. $3.16$44K - Aug 14, 2026STLN
Starling Oncology, Inc.
PurchaseDirect12K shares at avg. $6.54$78K - Aug 13, 2026STIM
Neuronetics, Inc.
SaleDirectCall Option (STIM 19FEB27 $5C)
100 shares at avg. $3.21- - Aug 13, 2026STLN
Starling Oncology, Inc.
SaleDirectCall Option (STLN 19FEB27 $9C)
100 shares at avg. $6.24- - Jul 21, 2026TOI
Oncology Institute, Inc.
PurchaseDirect18K shares at avg. $5.27$95K - Jul 14, 2026STIM
Neuronetics, Inc.
PurchaseDirect35K shares at avg. $1.78$62K - Jul 10, 2026TOI
Oncology Institute, Inc.
PurchaseDirect15K shares at avg. $5.85$88K - Jun 23, 2026TOI
Oncology Institute, Inc.
PurchaseDirect18K shares at avg. $5.02$90K - Jun 4, 2026TOI
Oncology Institute, Inc.
PurchaseDirect12K shares at avg. $4.75$57K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  XGN EXAGEN INC. | Purchase | 14,000 | $7.46 | $104,440 | Direct |
| Aug 14, 2026 |  STIM Neuronetics, Inc. | Purchase | 14,000 | $3.16 | $44,240 | Direct |
| Aug 14, 2026 |  STLN Starling Oncology, Inc. | Purchase | 12,000 | $6.54 | $78,480 | Direct |
| Aug 13, 2026 | STIM Neuronetics, Inc. | Sale Call Option (STIM 19FEB27 $5C) | 100 | $3.21 | - | Direct |
| Aug 13, 2026 | STLN Starling Oncology, Inc. | Sale Call Option (STLN 19FEB27 $9C) | 100 | $6.24 | - | Direct |
| Jul 21, 2026 |  TOI Oncology Institute, Inc. | Purchase | 18,000 | $5.27 | $94,860 | Direct |
| Jul 14, 2026 | STIM Neuronetics, Inc. | Purchase | 35,000 | $1.78 | $62,300 | Direct |
| Jul 10, 2026 | TOI Oncology Institute, Inc. | Purchase | 15,000 | $5.85 | $87,750 | Direct |
| Jun 23, 2026 | TOI Oncology Institute, Inc. | Purchase | 18,000 | $5.02 | $90,360 | Direct |
| Jun 4, 2026 | TOI Oncology Institute, Inc. | Purchase | 12,000 | $4.75 | $57,000 | Direct |
1-10 of 49 transactions